CARRIE STERLING: Open Payments
NPI 1528337219 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,580 in 65 payments from 19 companies in 2025. Trend: 2023 $2,176 · 2024 $1,473 · 2025 $1,580
Food & beverage: $1,538Education: $42
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $247 |
| Mallinckrodt Hospital Products Inc. | 2 | $176 |
| Calliditas Therapeutics US Inc. | 8 | $159 |
| ANI Pharmaceuticals, Inc. | 7 | $156 |
| Novartis Pharmaceuticals Corporation | 7 | $154 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| Fresenius USA Marketing, Inc. | 3 | $54 |
Products named: TAVNEOS, TERLIVAZ, TARPEYO, PURIFIED CORTROPHIN GEL, Kerendia, JARDIANCE, Fabhalta, JYNARQUE.
Industry payments across MD — which companies pay providers there.
